| Q38965273 | A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors. |
| Q37988199 | A miR image of stem cells and their lineages |
| Q35067988 | A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly. |
| Q34066554 | A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected]. |
| Q27349177 | A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia |
| Q38099048 | Aberrant microRNA expression in multiple myeloma |
| Q36780087 | Alcohol Use During Pregnancy is Associated with Specific Alterations in MicroRNA Levels in Maternal Serum |
| Q39701555 | Altered microRNA expression in mycosis fungoides |
| Q34427855 | An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma |
| Q34450493 | Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles |
| Q41815132 | BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma |
| Q36294566 | CFTR mediates bicarbonate-dependent activation of miR-125b in preimplantation embryo development |
| Q34391443 | Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases |
| Q38500323 | Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes |
| Q49796927 | Circulating and urinary microRNAs as possible biomarkers in kidney transplantation |
| Q34904013 | Circulating miRNA biomarkers for Alzheimer's disease |
| Q37693747 | Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis |
| Q55068347 | Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma. |
| Q26829583 | Clinical application of microRNA in gastric cancer in Eastern Asian area |
| Q37228812 | Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas |
| Q35021337 | Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
| Q42243553 | Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma |
| Q24618086 | Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs |
| Q35225279 | Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas |
| Q54362756 | Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. |
| Q37533750 | Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development. |
| Q34106877 | Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. |
| Q35909637 | Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies |
| Q34252178 | Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. |
| Q38190915 | Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias |
| Q34134744 | E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response |
| Q37798947 | Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers |
| Q24624514 | Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7 |
| Q38161582 | Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity |
| Q26772330 | Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response |
| Q37097751 | Epigenetics of the antibody response |
| Q35685797 | Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. |
| Q51016913 | Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma. |
| Q37786570 | Expression of miRNAs in Lymphocytes: A Review |
| Q34868346 | Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas |
| Q35974341 | Genetic lesions in diffuse large B-cell lymphomas |
| Q24596097 | Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia |
| Q36010283 | Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis |
| Q52857590 | Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides. |
| Q35080097 | Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma |
| Q24299894 | HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway |
| Q34389648 | Hmgb3 is regulated by microRNA-206 during muscle regeneration |
| Q35946250 | Identification and Analysis of the Porcine MicroRNA in Porcine Cytomegalovirus-Infected Macrophages Using Deep Sequencing |
| Q35067195 | Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations |
| Q37706993 | Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 |
| Q51864519 | Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia. |
| Q21090722 | Implication of IRF4 aberrant gene expression in the acute leukemias of childhood |
| Q101051138 | Integrative transcriptome and chromatin landscape analysis reveals distinct epigenetic regulations in human memory B cells |
| Q33950857 | LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. |
| Q45847205 | LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype |
| Q34399321 | Lactation-related microRNA expression profiles of porcine breast milk exosomes |
| Q37997926 | MiR-125 in normal and malignant hematopoiesis |
| Q34586343 | MiR-125b reduces porcine reproductive and respiratory syndrome virus replication by negatively regulating the NF-κB pathway |
| Q42703031 | Micro-RNA Expression and Function in Lymphomas |
| Q33941947 | MicroRNA 125b inhibition of B cell differentiation in germinal centers |
| Q33973612 | MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells |
| Q34293107 | MicroRNA and gene networks in human diffuse large B-cell lymphoma |
| Q36249115 | MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation |
| Q39580400 | MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. |
| Q38689170 | MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy |
| Q91879146 | MicroRNA profiling in canine multicentric lymphoma |
| Q52919265 | MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified. |
| Q34234677 | MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response |
| Q35072776 | MicroRNA profiling of primary cutaneous large B-cell lymphomas |
| Q27026073 | MicroRNA regulation of the germinal center response |
| Q38563711 | MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV. |
| Q35783359 | MicroRNA signatures in B-cell lymphomas. |
| Q35523881 | MicroRNA-125b potentiates macrophage activation |
| Q35006000 | MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors |
| Q38712795 | MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma |
| Q37607918 | MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q38064494 | MicroRNAs and lymphomagenesis: a functional review |
| Q35053331 | MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. |
| Q57814100 | MicroRNAs as Biomarkers of B-cell Lymphoma |
| Q37791755 | MicroRNAs as new player in rheumatoid arthritis |
| Q58010808 | MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma |
| Q90464161 | MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index |
| Q63246420 | MicroRNAs from saliva of anopheline mosquitoes mimic human endogenous miRNAs and may contribute to vector-host-pathogen interactions |
| Q28254647 | MicroRNAs in B-cell lymphomas: how a complex biology gets more complex |
| Q26824682 | MicroRNAs in B-cells: from normal differentiation to treatment of malignancies |
| Q38599607 | MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential |
| Q34549827 | MicroRNAs in lupus |
| Q38075896 | MicroRNAs in mantle cell lymphoma |
| Q35974211 | MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) |
| Q33877654 | MicroRNAs of the immune system: roles in inflammation and cancer |
| Q38095501 | MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer |
| Q33815996 | MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets |
| Q27010231 | MicroRNAs, Major Players in B Cells Homeostasis and Function |
| Q35909668 | Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling |
| Q37970680 | Molecular profiling of aggressive lymphomas |
| Q38988815 | NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms |
| Q37473357 | New insights into the regulation of human B-cell differentiation |
| Q33714060 | Next-generation sequencing identifies the natural killer cell microRNA transcriptome. |
| Q24645617 | Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas |
| Q33940931 | Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas |
| Q37768080 | Pathogenesis of diffuse large B cell lymphoma |
| Q34388477 | Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs disease |
| Q38985907 | Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma |
| Q39177128 | Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro |
| Q36939328 | Regulation of B-cell development and function by microRNAs. |
| Q43152809 | Regulation of LMO2 mRNA and protein expression in erythroid differentiation |
| Q93032482 | Regulatory mechanisms of B cell responses and the implication in B cell-related diseases |
| Q27016561 | Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) |
| Q38095676 | Role of microRNA in the pathogenesis of malignant lymphoma. |
| Q42923456 | Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma |
| Q54918383 | Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. |
| Q33893875 | Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL. |
| Q36889725 | Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program |
| Q34914103 | Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment |
| Q82180170 | Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia |
| Q64245615 | Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma |
| Q60916539 | Targeting the Bcl-2 Family in B Cell Lymphoma |
| Q55012595 | The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis. |
| Q39767910 | The Role of MicroRNA in Inflammatory Bowel Disease. |
| Q37831954 | The coming of age of microRNA for B cell lymphomas |
| Q37518164 | The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma |
| Q26858788 | The involvement of microRNAs in neurodegenerative diseases |
| Q92712443 | The matrix vesicle cargo miR-125b accumulates in the bone matrix, inhibiting bone resorption in mice |
| Q35307418 | The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
| Q30411597 | The urine microRNA profile may help monitor post-transplant renal graft function |
| Q35865929 | Uncovering MicroRNA Regulatory Hubs that Modulate Plasma Cell Differentiation |
| Q35853304 | Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant |
| Q54697317 | Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia. |
| Q91741405 | Xeno-miRNA in Maternal-Infant Immune Crosstalk: An Aid to Disease Alleviation |
| Q39433259 | miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells |
| Q33574184 | miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study |
| Q50074487 | miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity. |
| Q35669239 | miR-155 regulates HGAL expression and increases lymphoma cell motility |
| Q34517731 | miR-22 controls Irf8 mRNA abundance and murine dendritic cell development |
| Q38347455 | miRNAs in urine: a mirror image of kidney disease? |
| Q86893123 | microRNA in Malignant Lymphoma |
| Q37642868 | microRNAs in inflammation |